Clinical and Experimental Pediatrics

Search

Page Path

HOME
Search

Review Article

Oncology

Breaking the barrier: a guidelines-based review of antiangiogenesis drug resistance in pediatric cancer therapy

Nader Shakibazad, Mahdi Shahriari, Mani Ramzi

Clin Exp Pediatr. 2025;68(12):952-962. Published online November 24, 2025

Antiangiogenic therapy resistance in pediatric cancers involves alternative angiogenic pathways, microenvironmental support, hypoxia-driven signaling, metabolic reprogramming, and structural adaptations such as vascular co-option. Metabolic adaptation highlights tumor plasticity. Effective treatments combine immunotherapy with biomarkers. To address vascular endothelial growth factor limitations, emerging targets include hypoxia-inducible factor-2α, endoglin, CXCR4, angiopoietin/Tie2, and bispecific antibodies. In resource-constrained settings, the guidelines recommend low-dose chemotherapy plus oral multiantiangiogenic agents to ensure improved accessibility and treatment outcomes.

DOI: https://doi.org/10.3345/cep.2025.01809

Guideline

Endocrinology

2017 Clinical practice guidelines for dyslipidemia of Korean children and adolescents

Jung Sub Lim, Eun Young Kim, Jae Hyun Kim, Jae-Ho Yoo, Kyung Hee Yi, Hyun Wook Chae, Jin-Ho Choi, Ji Young Kim, Il Tae Hwang; the Committee of Dyslipidemia of Korean Children and Adolescents on behalf of Korean Society of Pediatric Endocrinology (KSPE)

Clin Exp Pediatr. 2020;63(12):454-462. Published online November 25, 2020

Web of Science 10 Crossref 11

Question: How are children and adolescents with dyslipidemia treated and managed in Korea?
Finding: 2017 guidelines recommend to measure nonfasting non-HDL-C as a screening test and introduce new diet methods: Cardiovascular Health Integrated Lifestyle Diet (CHILD)-1, CHILD-2-low-density lipoprotein cholesterol, and CHILD-2-triglyceride. Statin is the only drug approved in children older than 10 years.
Meaning: New clinical practice guidelines for treating and managing dyslipidemia of Korean children and adolescents are provided.

DOI: https://doi.org/10.3345/cep.2020.01340

MOST CITED ACCEPTED ARTICLES

Cited By 35	Neurodevelopmental outcomes of preterm infants
Cited By 32	Prevalence of anxiety, depression, and stress among parents of neonates admitted to neonatal intensive care unit: a systematic review and meta-analysis
Cited By 31	Gut microbiota affects brain development and behavior
Cited By 31	Long COVID in children and adolescents: prevalence, clinical manifestations, and management strategies
Cited By 28	Association of gut microbiota with obesity in children and adolescents

Pubertal induction in prepubertal males with hypogonadotropic hypogonadism: testosterone or gonadotropins?

Prioritizing maternal sleep: a public health strategy for preventing childhood allergic diseases

Longitudinal analysis of gut microbiota dysbiosis and bacterial signatures predictive of postoperative enterocolitis in children with Hirschsprung disease

Ingestion of foreign bodies and caustic substances in children: a narrative review on clinical evaluation and management update

External tracheal compression and mucosal injury in a neonate with cervical teratoma: a rare airway challenge

ARTICLE CATEGORY

Browse all articles >

BROWSE ARTICLES

FOR CONTRIBUTORS

Editorial Office: Korean Pediatric Society
#1606 Seocho World Officetel, 19 Seoun-ro, Seocho-ku, Seoul 06732, Korea
Tel: +82-2-3473-7306 Fax: +82-2-3473-7307 E-mail: office@e-cep.org

Clinical and Experimental Pediatrics is an open access journal. All articles are distributed under the terms of the Creative Commons Attribution NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/)

Copyright © 2025 by Korean Pediatric Society.